Literature DB >> 33322208

Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients.

Beatrice Macchi1, Caterina Frezza2, Francesca Marino-Merlo3, Antonella Minutolo4, Valeria Stefanizzi4, Emanuela Balestrieri4, Carlotta Cerva2,5, Loredana Sarmati2,5, Massimo Andreoni2,5, Sandro Grelli4,5, Antonio Mastino6.   

Abstract

Testing HIV-1 RNA in plasma by PCR is universally accepted as the ultimate standard to confirm diagnosis of HIV-1 infection and to monitor viral load in patients under treatment. However, in some cases, this assay could either underestimate or overestimate the replication capacity of a circulating or latent virus. In the present study, we performed the assessment of evaluating the HIV-1 reverse transcriptase (RT) activity by means of a new assay for the functional screening of the status of HIV-1 patients. To this purpose, we utilized, for the first time on blood samples, an adapted version of a real-time RT quantitative PCR assay, utilized to evaluate the HIV-1-RT inhibitory activity of compounds. The study analyzed blood samples from 28 HIV-1-infected patients, exhibiting a wide range of viremia and immunological values. Results demonstrated that plasma HIV-1 RT levels, expressed as cycle threshold values obtained with the assay under appraisal, were inversely and highly significantly correlated with the plasma HIV-1-RNA levels of the patients. Thus, an HIV-1 RT quantitative PCR assay was created which we describe in this study, and it may be considered as a promising basis for an additional tool capable of furnishing information on the functional virological status of HIV-1-infected patients.

Entities:  

Keywords:  HIV diagnostics; human immunodeficiency virus; quantitative PCR assay; reverse transcriptase; viral load

Year:  2020        PMID: 33322208      PMCID: PMC7763350          DOI: 10.3390/pathogens9121047

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  28 in total

1.  Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.

Authors:  Susan A Sufka; Guido Ferrari; Victoria E Gryszowka; Terri Wrin; Susan A Fiscus; Georgia D Tomaras; Herman F Staats; Dhavalkumar D Patel; Gregory D Sempowski; Nicholas S Hellmann; Kent J Weinhold; Charles B Hicks
Journal:  J Infect Dis       Date:  2003-03-13       Impact factor: 5.226

2.  A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants.

Authors:  Massimo Pizzato; Otto Erlwein; David Bonsall; Stephen Kaye; David Muir; Myra O McClure
Journal:  J Virol Methods       Date:  2008-12-05       Impact factor: 2.014

3.  Development and evaluation of a simple and effective RT-qPCR inhibitory assay for detection of the efficacy of compounds towards HIV reverse transcriptase.

Authors:  Francesca Marino-Merlo; Caterina Frezza; Emanuela Papaianni; Elena Valletta; Antonio Mastino; Beatrice Macchi
Journal:  Appl Microbiol Biotechnol       Date:  2017-09-30       Impact factor: 4.813

4.  Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

Authors:  Zheng Wang; Evelyn E Gurule; Timothy P Brennan; Jeffrey M Gerold; Kyungyoon J Kwon; Nina N Hosmane; Mithra R Kumar; Subul A Beg; Adam A Capoferri; Stuart C Ray; Ya-Chi Ho; Alison L Hill; Janet D Siliciano; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

5.  Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α.

Authors:  Beatrice Macchi; Emanuela Balestrieri; Caterina Frezza; Sandro Grelli; Elena Valletta; Ambroise Marçais; Francesca Marino-Merlo; Jocelyn Turpin; Charles R Bangham; Olivier Hermine; Antonio Mastino; Ali Bazarbachi
Journal:  Blood Adv       Date:  2017-05-05

6.  High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods.

Authors:  A Lovatt; J Black; D Galbraith; I Doherty; M W Moran; A J Shepherd; A Griffen; A Bailey; N Wilson; K T Smith
Journal:  J Virol Methods       Date:  1999-10       Impact factor: 2.014

7.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

8.  Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement.

Authors:  H Pyra; J Böni; J Schüpbach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  A highly sensitive aptamer-based HIV reverse transcriptase detection assay.

Authors:  Jeffrey J DeStefano; Irani Alves Ferreira-Bravo
Journal:  J Virol Methods       Date:  2018-04-06       Impact factor: 2.014

10.  Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay.

Authors:  J Böni; H Pyra; J Schüpbach
Journal:  J Med Virol       Date:  1996-05       Impact factor: 2.327

View more
  1 in total

1.  Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay.

Authors:  Francesca Marino-Merlo; Valeria Stefanizzi; Agnese Ragno; Lucia Piredda; Sandro Grelli; Beatrice Macchi; Antonio Mastino
Journal:  Life (Basel)       Date:  2022-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.